CD16‐158‐valine chimeric receptor T cells overcome the resistance of KRAS‐mutated colorectal carcinoma cells to cetuximab
Roberto Arriga(University of Rome Tor Vergata), Giuseppe Sconocchia(National Academies of Sciences, Engineering, and Medicine), Gianpietro Dotti(University of North Carolina at Chapel Hill), Alessio Ottaviani(Istituto di Farmacologia Traslazionale), Soldano Ferrone(Massachusetts General Hospital), Sara Caratelli(National Academies of Sciences, Engineering, and Medicine), Giulio C. Spagnoli(National Academies of Sciences, Engineering, and Medicine), Davide Lauro(University of Rome Tor Vergata), Giulia Lanzilli(Istituto di Farmacologia Traslazionale), Tommaso Sconocchia(Istituto di Farmacologia Traslazionale), Mario Roselli(University of Rome Tor Vergata), Andrea Coppola(University of Rome Tor Vergata), Carlo Cenciarelli(Istituto di Farmacologia Traslazionale), Giandomenica Iezzi(Ente Ospedaliero Cantonale)
Cited by 28
Related Papers
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
|Blood|2014|738
p53 signaling in cancer progression and therapy
|Cancer Cell International|2021|580